For research use only. Not for therapeutic Use.
Telazorlimab (GBR-830) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab can be used for the research of autoimmune diseases[1].
OX40 inhibition might have a therapeutic role in T cell-mediated diseases, including atopic dermatitis (AD)[1].
| Catalog Number | I042119 |
| CAS Number | 2126777-87-3 |
| Purity | ≥95% |
| Reference | [1]. Guttman-Yassky E, et, al. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Aug;144(2):482-493.e7. |
